- Home
- PXLW vs BNR Comparison
PXLW vs BNR Comparison
Compare PXLW & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- BNR
- Stock Information
- Founded
- PXLW 1997
- BNR 2014
- Country
- PXLW United States
- BNR China
- Employees
- PXLW N/A
- BNR N/A
- Industry
- PXLW Semiconductors
- BNR Medical Specialities
- Sector
- PXLW Technology
- BNR Health Care
- Exchange
- PXLW Nasdaq
- BNR Nasdaq
- Market Cap
- PXLW 28.1M
- BNR 38.3M
- IPO Year
- PXLW 2000
- BNR 2020
- Fundamental
- Price
- PXLW $6.85
- BNR $4.22
- Analyst Decision
- PXLW Strong Buy
- BNR
- Analyst Count
- PXLW 2
- BNR 0
- Target Price
- PXLW $15.00
- BNR N/A
- AVG Volume (30 Days)
- PXLW 75.3K
- BNR 29.7K
- Earning Date
- PXLW 08-06-2025
- BNR 08-21-2025
- Dividend Yield
- PXLW N/A
- BNR N/A
- EPS Growth
- PXLW N/A
- BNR N/A
- EPS
- PXLW N/A
- BNR N/A
- Revenue
- PXLW $34,246,000.00
- BNR $72,112,038.00
- Revenue This Year
- PXLW $5.21
- BNR $136.32
- Revenue Next Year
- PXLW $35.68
- BNR N/A
- P/E Ratio
- PXLW N/A
- BNR N/A
- Revenue Growth
- PXLW N/A
- BNR 0.53
- 52 Week Low
- PXLW $4.67
- BNR $2.18
- 52 Week High
- PXLW $14.16
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- PXLW 51.29
- BNR 63.77
- Support Level
- PXLW $7.01
- BNR $3.06
- Resistance Level
- PXLW $7.56
- BNR $3.50
- Average True Range (ATR)
- PXLW 0.75
- BNR 0.21
- MACD
- PXLW -0.02
- BNR 0.05
- Stochastic Oscillator
- PXLW 5.37
- BNR 95.65
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.